Prudential plc (PRU) Earnings Call Transcript & Summary

June 24, 2024

London Stock Exchange GB Financials Insurance shareholder_meeting 47 min

Earnings Call Speaker Segments

Operator

operator
#1

Hello, everyone, and welcome to today's Prudential plc Capital Management Update Call. My name is Seb, and I'll be the operator for your call today. [Operator Instructions] I will now hand the floor to Patrick Bowes to begin the call. Please go ahead.

Patrick Bowes

executive
#2

Thank you, Seb. Good morning, good afternoon, and welcome to our capital management update Q&A session. I am Patrick Bowes, Chief Investor Relations for Prudential plc. Together with me here today are our CEO, Anil Wadhwani; and Ben Bulmer, our CFO. I hope you've had a chance to review the RNS' slides and scripts that we published last night on our website. And we provided a brief trading update in the RNS, but we've yet to reach the end of the quarter, so we'll not be commenting any further. The RNS also confirmed that our half year results will be on the 28th of August. We -- I will now pass over to Anil and Ben to kick off with some opening remarks before opening up for questions. Thank you. Over to you, Anil.

Anil Wadhwani

executive
#3

Thank you, Patrick. Hello, everyone. I'm delighted to provide a capital management update today. As a result of our strong capital base, the progress that we've made on our strategic priorities as well as the recent clarification of the rating agency's treatment of IFRS 17 CSM, we will return $2 billion of capital to our shareholders through a buyback program over the next 2 years. This represents approximately 8% of our outstanding stock. The share buyback is consistent with our priorities for allocating capital. And with the current share price, we see this as a compelling opportunity to create value for our shareholders. We have importantly retained sufficient capital flexibility to further accelerate organic growth and enhance our capabilities. There is no change to our dividend policy and our expected annual dividend growth of 7% to 9% in 2024. Given our focus on quality growth in both value and cash and on account of the progress of the execution of our strategy, we remain confident in our full year 2024 new business growth and in achieving our 2027 financial and strategic objectives. We expect that the progress towards our 2027 financial objectives will increase the potential for further cash returns to our shareholders. Ben Bulmer, our Chief Financial Officer, will now summarize the key financial aspects of this capital management update. Ben?

Ben Bulmer

executive
#4

Thanks, Anil, and hello, everyone. So look, when we introduced our new strategy in August last year, we set out our capital allocation philosophy. That philosophy remains unchanged. But there's a few developments that have subsequently clarified management's view that there's capital available for return to shareholders. Firstly, as Anil briefly referenced, credit rating agencies have updated their methodologies to reflect the implementation of IFRS 17. We have comfortable leverage headroom even after the $2 billion buyback, and our pro forma Moody's leverage ratio would be 15% as of year-end 2023. Secondly, we now introduce a free surplus ratio and provide additional guidance as to how we think about the deployment of free surplus in the context of our growth aspirations, leverage capacity as well as our capital and liquidity needs. As no doubt you will have seen, the group's free surplus stock, which is our preferred measure of distributable shareholder capital stood at 8.5 billion at the end of 2023. The free surplus ratio we've defined is set as group free surplus plus the EEV required capital of the life business divided by the EEV required capital of the life business. And at the end of 2023, our free surplus ratio was 242%. Based on our current risk profile and our business units applicable capital regimes, we will seek to operate between a range of 175% to 200%. If we project the free surplus ratio to be above that operating range over the medium term and taking into account opportunities to reinvest appropriate returns and allowing for market conditions, capital will be returned to shareholders. So the $2 billion buyback we've announced today is forecast to reduce the free surplus ratio from 242% at year-end 2023 to marginally above 200% on a pro forma basis, and that's taking into account both the buyback and the 2023 second interim dividend. Looking forward, we expect significant acceleration in annual gross free surplus generation from the end of 2025. This will increase our financial flexibility and the potential for further cash returns to shareholders. Back to you, Patrick, for the Q&A session.

Patrick Bowes

executive
#5

Thank you, Ben. So now over to Seb. Please initiate the Q&A process. Thank you.

Operator

operator
#6

[Operator Instructions] And our first question comes from Kailesh Mistry from HSBC.

Kailesh Mistry

analyst
#7

A couple of things. I know you've just announced this share buyback, but the predictable question is would you think about your sort of payout policy after the buyback is completed? Is it fair to say that you would think about it on a payout ratio similar to your nearest peer? Secondly, in terms of financial resources, you highlight a 15% debt leverage on a Moody's basis. What is the additional debt capacity you calculate to maintain the AA rating? And lastly, just on new business trends, you highlight the sales trends in the first quarter -- sorry, in the second quarter are similar to the first quarter. Is there any further color you can provide on business mix and momentum and how that may or may not differ between Greater China and ASEAN?

Anil Wadhwani

executive
#8

Thanks, Kailesh. Let me start with the third question first, and then I'm going to hand over to Ben to respond to your first two. So we did put out in the RNS that the quarter 2 trends are similar to the one that we experienced in quarter 1. We are not going to get into specific market details. We look forward to having a much more in-depth conversation on our first half performance in August. But just to come back to what we had said at the quarter 1 results announcement. Against a strong prior period comparator that reflected what we believe was a significant outperformance in 2023, those comparators and base effects will come into play when we discussed the first half 2024 results. But as I said, we are looking forward to having the in-depth conversation on Hong Kong, Mainland China as well as in ASEAN when we speak to you in the August time frame.

Ben Bulmer

executive
#9

Thank you, Anil. Maybe I'll start with the payout ratio. Look, I think as you're rightly referencing, today's announcement is funded by stock. Our focus, as we've said before, in the near term is growth in NBP, and of course, accelerating operating free surplus generation. In terms of the free surplus ratio, as we think how we move across the objective period, I'm expecting to operate very much at the upper end of that ratio. And we've disclosed the profile of our gross operating free surplus generation ultimately progress towards those objectives means increased potential for further cash returns to shareholders. Whilst I expect free surplus generation to generate in the near term, of course, we need to be mindful of our $1 billion investment capability program, and of course, growth in regulatory capital as we layer on successive cohorts of profitable new business. In terms of today, as you know, our dividend policy is linked to growth in operating free surplus generation. That's not changed with today's announcement. And the underpin of 7% to 9% continues to apply in 2024. On your Moody's leverage point, so the 15% pro forma number I gave gives us headroom of slightly north of $2 billion.

Operator

operator
#10

The next question is from Edwin Liu of CLSA.

Edwin Liu

analyst
#11

If I may, two questions from me. Firstly, I know this is a $2 billion buyback program. But I guess, if the share price does go up subsequently, would you still fully execute this $2 billion program? Or would it be sort of the threshold that once the share price is above that, probably the program would not be fully executed? That's my first question. Second question is we noted your operating range of 175% to 200%, which is a bit lower than your nearest peer. Could you share some of the consideration behind? And that's the second question from me, yes.

Anil Wadhwani

executive
#12

Thanks, Edwin, and appreciate your questions. So I think the answer to the first question, we strongly believe that the stock price makes it highly compelling for us to initiate the buyback program as soon as we possibly can. And we will be in the market quite quickly to take opportunity of where our share price is. And as you would expect, we will continue to monitor our share price. The point being that we are very focused in making commercial decisions that are both focused on returning cash to our shareholders, and at the same time, driving quality value business. But that is something that we will monitor as we believe our share price does not reflect our fair value, as well as takes into account the performance that we have delivered in 2023 as well as back that up with double-digit new business profit growth in the first quarter of this year on an ex economic basis. I'm going to stop there. I'm going to now turn to Ben to talk about your second question.

Ben Bulmer

executive
#13

Thanks. Look, clearly, it wouldn't be right for me to comment on others. What I can say is that our operating range is obviously based on our risk profile and the applicable local capital regimes that we operate in. The range set out provides us capital to accelerate organic growth opportunities and provides a bit of additional resilience. In terms of our in-force book, if we step back, we're very much weighted towards health and protection with profits, style savings products and unit-linked style savings products. And these products, by their very nature, tend to have relatively low first order shareholder exposure to market risk.

Operator

operator
#14

Next question is from Laura Li at CGSI.

Zhiyi Li

analyst
#15

I have three questions. The first is about the leverage ratio. If there is future M&A, how high is Pru comfortable lifting its Moody's leverage ratio. Is [ not the way ] to target Moody's leverage ratio range? And second is about the required capital plus our operating -- operating free surplus ratio is based on the EEV required capital. What is the required capital and hence the target range surplus ratio deferred between the EEV and achieving this [ , say, in the future ] is adopted? And third question is also about the free surplus targets. Can you give us more opinion on whether PRU may have product needs that such it needs less capital to grow versus industrial average. Is the free surplus target based on your conservative projected future growth rate such as the current 2023 new business profit target? That's all.

Anil Wadhwani

executive
#16

Yes. Thanks for your questions. We may come back to you on your second question because you got cut out a little bit, so we may come back to you for your second question. But let me start with the future growth question. You're absolutely right, I think the buyback that we've announced today is an illustration of the financial discipline that we would like to operate under as well as importantly that we are retaining enough financial and capital strength to be able to deliver growth, if not surpass, the 15% to 20% range that we had spoken about when we announced our strategy late August. And we remain confident, as I said, that we have enough financial muscle to be able to pursue the growth opportunities that exist in our Asian and African markets. I'm going to turn to Ben to talk about the leverage ratio. And if you could just kind of once again just clarify the second question.

Ben Bulmer

executive
#17

Yes. I think I caught that. It's Ben here. So yes, on the leverage ratio, so Moody's has set sort of a general default target leverage range of between 5% and 20% for companies targeting a AA rating. And within that, they look to count 50% of the net CSM. We've been waiting for some clarity on this. We've spent time with the rating agencies, all three of them, actually over the last month. As I referenced earlier to Kailesh's question, we're operating at about 15%. We've got just over north of $2 billion to the upper end of that headroom. I think your second question, and tell me if I got this wrong, was would required capital of the operating ratio change materially if we were to look at this through a TEV lens, I can't tell you exact numbers, but I think conceptually it would be very similar. You wouldn't see a change in required capital. And I wouldn't expect the free cash flows to materially change.

Operator

operator
#18

The next question comes from Andrew Crean from Autonomous.

Andrew Crean

analyst
#19

I have three questions. Firstly, the mood music today is very different from the full year figures where there was much more talk of inorganic and bancassurance deals. Could you give us a sense, as you look forward over the next few years, to what level of money you're thinking about in terms of potential bancainsurance deals? Secondly, in terms of calculating the capital requirement for the FSG each year, could you tell us what ratio of required capital because clearly, the way you report it, it's on 100% required capital, which is too low. I mean are you -- should we build in sort of 175% or 200% of capital requirements in terms of the real FSG? And then thirdly, a point of clarification. When you say the second quarter new business is similar to the first quarter new business. Do you mean in dollars million terms or in terms of growth rate versus the prior year just as a definitional point.

Anil Wadhwani

executive
#20

Thanks, Andrew. Let me take your question third, which is relatively straightforward. So when we spoke about the trends, it was more from a year-on-year growth perspective and not from an absolute dollar perspective. In terms of your first question on bancassurance and inorganic, so let me kind of step back. When we did announce our strategy late August last year, we had been quite explicit that our primary focus would be organic growth, given the profitability and the returns that we continue to see in terms of deploying capital to drive our organic growth. We also mentioned that we were keen to build our capabilities so that we create a much more sustainable value-creating platform over the medium to long term. In terms of bank partnerships, so that we provide an additional level of clarification and color, we would like to pursue bank partnerships that complement the strength that we have in our agency force in some of our key markets. Now while doing this, you could expect that we will be contrasting and comparing this with returns that we would get if we were to return the same capital back to our shareholders. But I think providing a lens of diversification, then you simply have to look at our 2022 performance, which was largely bancassurance-led versus 2023. When the borders opened up, it was largely agency-led. And in terms of the size, Andrew, these are not massive Pan-Asian deals. These will be typically in country, much smaller sizes, but something that I believe will provide us a greater level of diversification as we look at expanding our distribution in some of our key ASEAN markets in specific. But I'm going to stop there and turn to Ben to answer the second question.

Ben Bulmer

executive
#21

So you're right. Our reported basis has 100% of prescribed capital requirements that reflect the regulations in each jurisdiction and I don't think we're unique in that. Of course, for our larger balance sheet, this can be a sort of [ one in 200% ] sort of level. But what we're saying today is we're electing to hold distributable capital in excess of this at 175%. Now dipping below that momentarily doesn't necessarily stifle growth, but I'd likely look to take management actions. So I think as we think about cash distribution going forward, yes, absolutely. Keep in mind the 175% level that we've set out today.

Operator

operator
#22

Next question is from Thomas Wang at Goldman Sachs.

Thomas Wang

analyst
#23

A couple of questions. Firstly, you mentioned on the slide, the operating free surplus generation target $4.4 billion. With this buyback, do you feel the need to adjust it because, I mean, rough calculation, that's going to remove $100-plus million or so from 2027 free surplus generation. So just want to quickly check do you feel the need to make more change to that? And secondly, on this excess capital of 75% to 100% target above the required capital, do you have any sort of comfort range in terms of how much of that is that versus equity within the excess capital?

Anil Wadhwani

executive
#24

Yes, sure.

Ben Bulmer

executive
#25

If I can kick off on, Thomas, your first question. No, absolutely no change to our OFSG objectives. Across the funding that's earmarked for today's announcement is set in topco in our holdco cash that, given its geography, doesn't impact gross operating free surplus generation quantums, but kind of comes through in the net number. So no change to that. I think I caught half of your second question. If you wouldn't mind just repeating it, sorry.

Thomas Wang

analyst
#26

No problem. Just excess capital on top of the required -- excess free surplus on top of the required capital. Do you have any -- currently, I think, it's $8-plus billion. Within that [ $3.5 billion or so is debt ]. Do you have any sort of comfort range of how much of that will be debt financing going forward?

Ben Bulmer

executive
#27

Well, I think what -- and given the certainty we recently got around leverage ratios, what we're saying is we will likely use that flexibility to pursue select partnership opportunities. I think Anil has touched on some of that. I'm certainly happy doing that. In addition to that, of course, because we've set out a range, there are elements of capital available in that free surplus on the balance sheet that we can use to accelerate organic growth. And we've never been shy of saying that it's our aim, if we can, to exceed the growth targets that we set for ourselves in 2027.

Operator

operator
#28

The next question is from Andrew Sinclair at Bank of America.

Andrew Sinclair

analyst
#29

Three for me, please. So first, you've said a couple of times that investment decisions will be judged against the alternative of returning capital to shareholders. How can we evaluate that? What valuation multiples are you considering? And will you give some updates to targets or some valuation multiples when you do sign any partnership opportunities? That's question one. Question two, just to understand the $1 billion of investment spend. What impact should we think of from that on the ratio, and just any comments around that? And third was just on the 15% to 20% new business compound target. Can you give me an idea, what would that be if you adjusted it for today's economics?

Anil Wadhwani

executive
#30

Thanks, Andrew, and let me start with your first question and I'll answer the third one as well. And I'll ask Ben to talk about specifically the $1 investment and the progress that we are making and what you could expect in that regard. In terms of evaluating our bank partnerships versus returning capital to our shareholders, clearly, we have certain thresholds that we evaluate these banks partnerships on. Now as you could imagine, these are commercially sensitive thresholds. So we can't be more explicit about it. But rest assured, there's a high degree of evaluation when you are comparing and contrasting with the dollar invested in the bank deals versus when we are returning that to the shareholders. I also wanted to point out, as I've kind of mentioned on a number of occasions previously, is that the bancassurance margins are quite healthy. They are not as strong as what you would expect from agency, rightfully so, but they are quite healthy. And we reflect the entire economics, the fully loaded economics, of our bancassurance partnerships in the margins that we disclose. I think that's a very important factor that you need to note, and this makes us believe that these are still accretive and do provide a level of diversification wherever where we have agency strength. In terms of your 15% to 20% new business profit question and whether it is going to account for the interest rate movement, I think we've been quite explicit about that, again, when we set the targets that it's going to be on an ex economic basis. And that is something that we continue to report as you would have seen in our quarter 1 earnings results as well. I'm going to stop there, and I'm going to talk -- turn to Ben to talk about the $1 billion.

Andrew Sinclair

analyst
#31

Sorry, just before we move on to -- just before we move on to Ben, just if I can, Anil, almost combining those 2 questions. I mean, I understand the difficulties and commercial sensitivities around bancassurance deals. But I think shareholders will very much appreciate the capital return today, but also will want to understand what they are getting from any of these bancassurance deals. I mean, you said that those targets originally as being organic. Is that -- do you see scope to increase your targets once you've done a couple or even some bancassurance transactions?

Anil Wadhwani

executive
#32

Yes. So I think, Andrew, firstly, if you look at our aggregate portfolios, right, the IRRs on our current portfolio continue to remain in excess of 25% with payback periods of less than 4 years. So I think that's a good indicator for you as to how we kind of think about some of these things. Now as you can imagine, this is a portfolio and not deal-specific and I just want to be very, very clear about that. But as you would expect, we can't get into every single bancassurance partnership commercials purely because of sensitivity reasons. But we understand that the bar is high, and you can take great confidence based on the announcement that we have made of returning $2 billion of capital that we are being very focused on both driving quality value growth, but at the same time, focused on returning capital back to our shareholders. And the last point to -- similar to what I was responding to Andrew's question, these deals are not large as compared to what you would have probably experienced us do in the past. For example, with the likes of Standard Chartered or UOB who have been excellent in terms of our partnership and the value that they have created. These are going to be much smaller and much more in-country, in-markets that are of strategic importance to Prudential.

Ben Bulmer

executive
#33

Yes, thanks. So thanks for your question on the $1 billion investment. We're making good progress on deploying that capital, and I'll be able to tell you more when we meet at the interim results. Just by way of reminder, though, as people try to model out our free cash flows. We, in 2023, have invested just over $130 million, so we have just short of $900 million to go to be deployed in 2024. I'm expecting that quantum to be around $250 to $300, and similarly, in 2025, which in part accounts for at least some of the shape that you're seeing in the acceleration of gross OFSG.

Operator

operator
#34

The next question is from Dom O'Mahony from BNP Paribas.

Dominic O''mahony

analyst
#35

Three from me, if that's okay. First, maybe it's too early to ask this, but you're clear in saying that the new capital management framework, combined with your targets such, could lead to further capital returns. I'm just wondering whether you expect to reexamine your capital position on an annual basis, on a regular basis or whether it's likely to be more ad hoc when you think about additional capital returns? Second question, just a technical one, on the metric. So it's capital excluding the intangibles. I wonder if, firstly, you might just explain why that is. I mean, as I understand it, they do contribute to capital. In what sense is it important to exclude them from the ratio? And then relatedly, if you do agree further banca partnerships and if there is an asset value on those partnerships, presumably those assets will be excluded in capital as well, but if you could convert that, that would be helpful. And then lastly, just on the 2027 targets, you've made a couple of clarifications in the release, which is very helpful. You say that you'll reach those targets primarily through growth rather than, say, margin. I wonder if you might just expand on that a little. Should we anticipate that the shape of free surplus emergence from new business vintages will be similar to 2023? Or actually, might you see similar NBP margins, but earlier emergence? And might that help get towards those targets?

Ben Bulmer

executive
#36

I'll have a go at those three, if that's okay, Anil. So maybe if I start with that last one to do them in the reverse order. So I think, for us, the 2023 cohort of new business have a slightly weaker signature candidly than I would have liked. There was a greater weighting than historically towards Hong Kong savings products and a lower weighting from a number of countries that typically have slightly earlier cash signatures. We certainly want to improve on that new business cash signature. We have done some repricing, including here in Hong Kong. There are some other actions we've alluded to, clearly, Dom, as you know. We really need to tackle variances, and we talked about setting a provision on medical claims. It is early days in the capability build. The more we can do on health and agency, frankly, help with the shape of those cash flows. And I would expect some mix normalization in terms of country mix. So more Singapore, for example, helps with the sort of overall portfolio cash signature. So we are looking to improve that, you're absolutely right. I guess, when we were referring to NBP and sort of not relying on margin build necessarily, that was sort of more of a reference to sort of country mix, channel mix as opposed to not actively managing our product set. Of course, we're going to do that. Your question, going in reverse order, on intangibles, why have we excluded them, basically because we want to get to a deployable capital ratio, in essence. GWS kind of works at a group level when we're thinking about stat solvency. But ultimately, we need to pay the bills and deployable capital and having a keen eye on that tends to bite before GWS does. And to the extent, to Anil's point on -- to the extent we do further select partnerships, we tend to capitalize a degree of that funding. We have the upfront, you can see it sat on our balance sheet. It is fully reflected in the margins we write. And indeed, the cash flows we provide, the strain we give. So there is a degree of visibility there notwithstanding the sensitivity of commercials. And then to your first question on examination of capital that I think the simple answer to that is, yes, frequently. We actively look at the capital stack, think about how we're deploying that, how we are creating the best returns for our shareholders. And I hope last night's announcement was good evidence of that.

Dominic O''mahony

analyst
#37

I'm sorry. I just wanted to clarify, if you do put an asset value on the any bancassurance partnerships agreed in the future, presumably those would also be deducted as intangibles from capital?

Ben Bulmer

executive
#38

Yes. The short answer is yes.

Operator

operator
#39

The next question is from Farooq Hanif at JPMorgan.

Farooq Hanif

analyst
#40

Anil, Ben and Patrick, I'm sure it's been a lot of work to get to this place. But firstly, my understanding was that you were in active conversations on some bank deals and were kind of waiting to see where those would turn out before you'd made this announcement. So I was just wondering whether that's still ongoing and that you just feel confident in giving this money -- this commitment back? Or is it the case that we're probably not going to hear something active on partnerships this year? Secondly, you talked about the increased confidence in your targets, particularly around OFSG. Now you've talked about the improved profit signature from new business that you're trying to create that will get you to that $4.4 billion-plus. But can you also talk about how much the $1 billion investment is going to help with those steps to get to over $4.4 billion? And then finally, very quickly, I'm not sure if you answered an earlier question, but you only give the EPS guidance to 2024, which makes sense because that's what you've given previously. But are you considering higher dividend growth or something that's actually more closely aligned with free surplus generation?

Anil Wadhwani

executive
#41

Thanks, Farooq. So let me start with the banca pipeline, and yes, we did mention about the active conversations. And unfortunately, I don't have any new news to share with you except the fact that those conversations are ongoing. Again, just to kind of provide clarity, and I might be repeating myself here, is that these are specific in-country deals so they're not big in size as you would compare to some of the more regional partnerships that we engage on. And to -- then in my earlier comments, we are going to be selective. And we'll have no issues in walking away from these bank transactions if they don't meet our return threshold, and this goes to Andy's question around the way we evaluate a bank partnership versus returning it to our shareholders. So yes, there is some degree of clarity, but I don't have a decision to give you right now on some of the ones that we are pursuing. But I guess the additional color in terms of size, in terms of the fact that we are going to be selective and we will not hesitate to walk away from them if they don't meet our return thresholds. So Ben, you want to go to the bank space?

Ben Bulmer

executive
#42

On the -- Farooq, I think you were asking about dividends. I mean, no change in policy today as we've set out. What I would say is the underpinning of 7% to 9% is, of course, on the absolute dividend number. So to the extent we've got a lower amount of outstanding stock, obviously, that's a tailwind for DPS, if you like. Your second question on increased confidence around OFSG and what does more health and agency do for that, can I come back to you at the interims where I can actually give you some stats around that rather than giving an oblique trust-me answer. I think that would be more helpful.

Patrick Bowes

executive
#43

And Farooq, just to answer your first question. The timing of the announcement, obviously, we -- you will have noticed we have a consent period that has to pass to get permission to transact, and obviously, we wanted to be able to execute during the course of this year. So we've undertaken a transaction with a counterparty that allows us to start that transaction early and continue through close periods and so forth. And obviously, at the current time, we believe the share price provides an attractive point to start executing this process.

Operator

operator
#44

The last question then comes from Larissa Van Deventer from Barclays.

Larissa van Deventer

analyst
#45

Two from my side and one is actually just to clarify -- actually make that three on which ones to clarify. On the growth in the dividend, can you just confirm that I hear that you said that is a total nominal amount, not on a DPS basis, is the first question. The second one, do you have a price point where you would switch from buybacks to rather increasing the ordinary dividend yield or how should we think about that? And the last one on the $1 billion. You said that you were invested in customer distribution and then health and technology and data. Is any of those areas receiving particular attention at the moment? Or are you spending the amount for this year proportionately throughout those three?

Anil Wadhwani

executive
#46

Thank you for your questions. Let me start with the third question, and then I will have Ben answer the first and the second one. So we are making progress on all our strategic enablers. And obviously, as we had said, the primary focus again for us would be distribution and ensuring that we are investing in growing our distribution as well as investing in technology capabilities to be able to provide a much more seamless experience to both our agents as well as the experience that will then convert from agents providing that similar experience to our customers. And the second one is we now have stood up our health vertical. And again, we are making some quite decisive progress in terms of how we are thinking about repricing, how we're thinking about the product set, how are we thinking about underwriting as well as fraud base and abuse. And that is something that we will be happy to provide you greater clarity when we speak to you in the August time frame. Ben, you want to take the first and second?

Ben Bulmer

executive
#47

Yes, sure. Maybe just to add to that one, Anil and Larissa, this is sort of quoting from the full year '23 numbers. The split of the 130, if you recall, was 70 distribution, 50 customer and then 13 health. And obviously, we can update on those at the end of August. On the dividend question, yes, you're right, it's a nominal. And then in terms of your second point, clearly, we'll look at market conditions and think about returns and ultimately reserve the right to change as we move through time.

Operator

operator
#48

We'll take another question from William Hawkins, KBW.

William Hawkins

analyst
#49

I've got three, but I just heard what Patrick said, so I'll keep it to one and win a brownie point. The $6 billion capital resources, can you just give us a hint of how you think that's going to grow over time in line with the other metrics that you've got? So if I'm thinking about the 15% to 20% new business growth, the CSM runoff and that kind of thing, what does that imply about how the $6 billion capital resources is going to grow, please?

Ben Bulmer

executive
#50

Yes. Thanks, Will. It's hard to give a simple reference metric to point to. Clearly, it's going to grow with the balance of liabilities we have on the balance sheet as the book grows. My recollection is thinking about 2023 growth that quantum grew roughly 10% year-on-year whereas, I think, in terms of the [ build of ] shareholder, assets, liabilities, it was around 8%. But yes, difficult to give a very simple rule of thumb. Fortunately, the answer is as the book -- grows in line with the book.

Patrick Bowes

executive
#51

The shape and size of the book is to [indiscernible] as well, okay? Sorry, was there anything else, William? You had a couple.

William Hawkins

analyst
#52

No, don't worry. That's fine. I'll follow up.

Patrick Bowes

executive
#53

Okay. Thank you. Very much delighted to provide you the capital management for you today. And obviously, IR team's at your disposal to answer any detailed modeling questions and for preclosed period roundups. And we look forward to speaking to you at the interim results at the end of August. Thank you very much for your attention.

Anil Wadhwani

executive
#54

Thank you, everyone. Have a good day. Bye-bye.

Ben Bulmer

executive
#55

Thank you. Cheers.

Operator

operator
#56

This concludes today's conference call. Thank you all very much for joining.

Read the full transcript via the API

You're viewing the first half of this call. Get the complete Prudential plc transcript — plus 251,000+ transcripts from 12,000+ companies, speaker segments, AI summaries and full-text search — through the EarningsCalls.dev API.

Get the API View API docs →

This call discussed

For developers and AI pipelines

Programmatic access to Prudential plc earnings transcripts and 251,000+ others is available through the EarningsCalls.dev REST API. Plans from $24.99/month — full transcripts, speaker segments, full-text search, and the recently-added /api/v1/transcripts/recent polling endpoint for ETL pipelines.